论文部分内容阅读
Fasudil is a selective and potent RhoA/Rho kinase (ROCK) inhibitor and vasodilator.Since it was discovered, it has been used for the treatment of cerebral vasospasm, as well as to improve the cognitive decline seen in stroke victims.And it has been found to be effective for the treatment of pulmonary hypertension, and enhance memory and improve the prognosis of Alzheimers patients.In this study, we characterized the effects of Fasudil on Kv+ channels and compared its effects with the well-established Kv7 opener retigabine.A perforated whole-cell patch technique was used to record Kv7 currents expressed in HEK293 cells and M-type currents from rat DRG neurons.